| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 05/07/2009 | WO2009057725A1 Protease-treated jew's mallow extract composition, method for production of the composition, and anti-hypertensive agent or beverage/food comprising the composition |
| 05/07/2009 | WO2009057724A1 Jew's mallow-derived synthetic-resin-adsorbed fraction composition having vasodepressing activity, vasodepressing agent or food/beverage comprising the adsorbed fraction composition, and method for producing the adsorbed fraction composition |
| 05/07/2009 | WO2009057685A1 Pharmaceutical composition for treating overactive bladder |
| 05/07/2009 | WO2009057056A2 Use and device to prevent ventilator acquired pneumonia using nitric oxide |
| 05/07/2009 | WO2009056256A1 Use of megestrol acetate having improved solubility for the treatment of cancer cachexia |
| 05/07/2009 | WO2009055934A1 Treatment of fibrillinopathy or elastinopathy using granzyme inhibitors |
| 05/07/2009 | WO2009023160A3 Novel inhibitors of bacterial sortase enzymes and methods of using the same |
| 05/07/2009 | WO2009013723A3 Ethyl pyruvate alone or in combination with mi cro- clustered water and use of the same |
| 05/07/2009 | WO2009009727A3 Ghrh analogs and therapeutic uses thereof |
| 05/07/2009 | WO2008155081A3 Substituted aromatic heterocyclic compounds as fungicides |
| 05/07/2009 | WO2008155035A3 Oxazolidinones for the treatment and prophylaxis of sepsis |
| 05/07/2009 | US20090118469 High-Affinity Antagonists of ELR-CXC Chemokines |
| 05/07/2009 | US20090118371 Delta 6 Desaturase From Thraustochytrid and its Uses Thereof |
| 05/07/2009 | US20090118322 Agent for repairing corneal sensitivity containing amide compound |
| 05/07/2009 | US20090118313 Treating atherosclerosis by administering 1-(N-(2-(diethylamino)ethyl)-N-(4-(4-trifluoromethylphenyl)benzyl)aminocarbonylmethyl)-2-(4-fluorobenzyl)thio-5,6-trimethylenepyrimidin-4-one or a salt; coadministering an antioxidant probucol; inhibitor of platlet activating factor acetylhydrolase |
| 05/07/2009 | US20090118278 Compositions useful as inhibitors of gsk-3 |
| 05/07/2009 | US20090118277 3 Unsubstituted N-(aryl- or heteroaryl)-pyrazolo[1,5-a]pyrimidines as Kinase Inhibitors |
| 05/07/2009 | US20090118233 Heterocyclic compounds having inhibitory activity against HIV integrase |
| 05/07/2009 | US20090118221 Method of treating arrhythmias |
| 05/07/2009 | US20090118182 Fibroblast Growth Factor-Like Polypeptides |
| 05/07/2009 | US20090118169 Novel compounds and pharmaceutical use thereof |
| 05/07/2009 | US20090118166 Conditioned Decellularized Native Tissues for Tissue Restoration |
| 05/07/2009 | US20090118160 Heterocyclic compounds and methods of use |
| 05/07/2009 | US20090117566 Compositions and methods for the diagnosis and treatment of tumor |
| 05/07/2009 | US20090117195 Hydrophilic Particles Based on Cationic Chitosan Derivatives |
| 05/07/2009 | US20090117188 Methods of Augmenting or Repairing Soft Tissue |
| 05/07/2009 | US20090117134 Truncated EGF Receptor |
| 05/07/2009 | US20090117133 POLYMERIC IMMUNOGLOBULIN FUSION PROTEINS THAT TARGET LOW AFFINITY FCyRECEPTORS |
| 05/07/2009 | US20090117092 Collagenolytic active enzyme containing compositions, and their use in the dental field |
| 05/07/2009 | US20090117072 Treatment of periodontal disease |
| 05/07/2009 | US20090117046 Methods for evaluating genetic susceptibility and therapy for chronic inflammatory diseases |
| 05/07/2009 | US20090117045 Soy or lentil stabilized gold nanoparticles and method for making same |
| 05/07/2009 | US20090117044 Method for quantifying the uptake of at least one radiotracer in a body region of a patient of interest to a positron emission tomography measurement |
| 05/07/2009 | US20090117037 Methods Of Treatment Using CTLA-4 Antibodies |
| 05/07/2009 | DE102007052114A1 Verfahren zur Modulation der Funktion, des Wachstums oder der Differenzierung einer Zelle A method of modulating the function of the growth or differentiation of a cell |
| 05/07/2009 | DE10010113B4 Natives Schwammkollagen, Verfahren zu seiner Isolierung und seine Verwendung, sowie natives nanopartikuläres Schwammkollagen, Verfahren zu seiner Herstellung und seine Verwendung Native collagen sponge, process for its isolation and its use, as well as native nanoparticulate sponge collagen, process for its preparation and its use |
| 05/07/2009 | CA2742252A1 Cytidine analogs for treatment of myelodysplastic syndromes |
| 05/07/2009 | CA2704298A1 Pharmaceutical composition for treating overactive bladder |
| 05/07/2009 | CA2703904A1 Substituted diazepan orexin receptor antagonists |
| 05/07/2009 | CA2703693A1 Anti-fatigue agent comprising amino acid composition |
| 05/06/2009 | EP2055716A1 Kallikrein-inhibiting "Kunitz Domain" proteins and nucleic acids encoding the same |
| 05/06/2009 | EP2055705A1 Compound having cyclic group bound thereto through spiro binding and use thereof |
| 05/06/2009 | EP2055696A1 Acid addition salts of mandelic acid derivatives |
| 05/06/2009 | EP2055325A2 Tissue regenerative composition |
| 05/06/2009 | EP2055308A1 Pharmaceutical for promoting functional regeneration of damaged tissue |
| 05/06/2009 | EP2055303A2 8-chloro-6, 11-dihydro-11-(4-piperidylidene)-5H-benzo [5,6] cyclohepta [1,2-b] pyridine oral compositions |
| 05/06/2009 | EP2055302A1 Method for the improvement of islet signaling in diabetes mellitus and for its prevention |
| 05/06/2009 | EP1478398B1 New medicinal compositions on the basis of anticholinergic agents and egfr kinase inhibitors |
| 05/06/2009 | EP1465861B1 Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors |
| 05/06/2009 | EP1458355B1 Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol |
| 05/06/2009 | EP1436264B9 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain |
| 05/06/2009 | EP1414525B1 2-(3,5-bis-trifluoromethyl-phenyl)-n-¬6-(1,1-dioxo-1.lambda.6-thiomorpholin-4-yl)-4-(2-methyl or 4-fluoro-2-methyl substituted)phenyl-pyridin-3-yl -n-methyl-isobutyramide |
| 05/06/2009 | EP1385506B1 Acylated piperidine derivates as melanocortin-4 receptor agonists |
| 05/06/2009 | EP1385480B1 Liposomes |
| 05/06/2009 | EP1373265B1 Substituted 2,6-diamino-3,5-dicyano-4-aryl-pyridines and their use as adenosine receptor-selective ligands |
| 05/06/2009 | EP1308440B1 Piperidine derivatives and drugs containing these derivatives as the active ingredient |
| 05/06/2009 | EP1272193B1 Synergistic combination therapy for treating cancer |
| 05/06/2009 | EP1242082B1 Methods and compositions for the prevention and treatment of atherosclerosis, restenosis and related disorders |
| 05/06/2009 | EP1200114B1 Ppar delta inhibitors for the treatment of cardiovascular diseases |
| 05/06/2009 | EP1173155A4 Gum pad for delivery of medication to mucosal tissues |
| 05/06/2009 | EP1165114B1 Use of a lectin or conjugates for modulation of c-fibre activity |
| 05/06/2009 | EP1152750B1 Spontaneously dispersible n-benzoyl staurosporine compositions |
| 05/06/2009 | CN101426792A Pyrazolopyrimidines as therapeutic agents |
| 05/06/2009 | CN101426775A Oxadiazolidinedione compound |
| 05/06/2009 | CN101426763A Sulfide and disulfide compounds and compositions for cholesterol management and related uses |
| 05/06/2009 | CN101426499A Modulators of muscarinic receptors |
| 05/06/2009 | CN101426491A GIP secretion inhibitor |
| 05/06/2009 | CN101426480A Utilization of inhibitors of rho-kinases for stimulating nerve growth, inhibiting scar tissue formation and/or reducing a secondary lesion |
| 05/06/2009 | CN101426378A Treatment of poultry for increasing the feed conversion rate or for reducing the incidence of ascites |
| 05/06/2009 | CN101424987A Health-care medical-magnetic mouse pad |
| 05/06/2009 | CN101423508A Method for preparing flavonoid from lotus leaf and drug application thereof |
| 05/06/2009 | CN101423491A Acenaphtho-heterocycles compounds and application thereof in preparation of BH3 analogue Bcl-2 family protein inhibitor |
| 05/06/2009 | CN101422600A Use of scorpion source immunoloregulation polypeptide in preparing medicine for treating multiple sclerosis disease |
| 05/06/2009 | CN101422532A Medicine for preventing and treating chronic lymphocytic thyroiditis |
| 05/06/2009 | CN101422505A Foot-and-mouth disease vaccine and immunological stress resistance agent of other livestock and poultry and use thereof |
| 05/06/2009 | CN101422490A Dioxin elimination promoter |
| 05/06/2009 | CN101422487A Bear gall soft capsules and preparation method thereof |
| 05/06/2009 | CN101422463A New use of sodium-ion channel blocker compound in clearing biosome endotoxin |
| 05/06/2009 | CN100484954C Method for purifying drug active protein by cation exchange chromatogrphy |
| 05/06/2009 | CN100484934C Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinase |
| 05/06/2009 | CN100484933C Novel pyrazine compounds, their use in preparing medicament for treating diseases correlated with serotonin |
| 05/06/2009 | CN100484571C Application of semen momordicae extract containing triterpene saponin |
| 05/06/2009 | CN100484569C Medicament for mobilizing pluripotent stem cells from tissue into peripheral blood |
| 05/06/2009 | CN100484559C Chinese medicine preparation for treating acute and chronic appendicitis |
| 05/06/2009 | CN100484533C Active constituent normal-temperature superhigh pressure extracting method from manyprickle acanthopanax material |
| 05/06/2009 | CN100484524C Thiazolidine carboxamide derivatives as modulators of the prostaglandin receptor |
| 05/06/2009 | CN100484512C Method for preparing high oxygen large transfusion fluid |
| 05/06/2009 | CN100484410C Process for preparing vanilla-bitter gourd tea |
| 05/05/2009 | US7528255 Hydroxy, ω-carboxyaryl substituted diphenyl ureas and dirivatives thereof as raf kinase inhibitors |
| 05/05/2009 | US7528252 Derivatives of triazoly-imidazopyridine useful as ligands of the adenosine A2a receptor and their use as medicaments |
| 05/05/2009 | US7528249 Amidating a cyclic carboxylic acid (methyl 1-[N-(3-methylbutyl)carbamoyl]cyclopentane-carboxylic acid) with an aminobenzodiazepinone (3-amino-1-methyl-5-phenyl-3H-benzoazepin-2-one) |
| 05/05/2009 | US7528240 Method for producing human anti-thymocyte immunoglobulins |
| 05/05/2009 | US7528226 TGFβ1-inhibitor peptides |
| 05/05/2009 | US7528169 drugs separated from fermentation cultures of filamentous fungi, having angiogenesis inhibitory activity in a low oxygen condition |
| 05/05/2009 | US7528164 e.g. 2-Amino-4-(3-bromo-4,5-dimethoxyphenyl)-3-cyano-7-methyl-4H-pyrrolo [2,3-h]chromene; antiproliferative, antitumor, anticarcinogenic agent |
| 05/05/2009 | US7528156 Such as N-[2-(3-{[1-(3,4-dichlorobenzylpiperidinyl]aminohydroxypropoxy)phenyl]acetamide; antiinflammatory agents, antiarthritic agents; chronic obstructive pulmonary disease, asthma, multiple sclerosis |
| 05/05/2009 | US7528149 e.g. N-[1-(2-aminoethyl)-4-piperidinyl]-7-methyl-3-(8-quinolinylmethyl)-3H-imidazo[4,5-b]pyridin-2-amine tetrahydrochloride trihydrate; immunostimulant; lower respiratory tract illness during infancy and childhood, asthma, pneumonia |
| 05/05/2009 | US7528140 Substituted pyrrolo[3,2-d]pyrimidines as glycogen synthase kinase (GSK) inhibitors |
| 05/05/2009 | US7528137 Compounds, compositions, and methods |
| 05/05/2009 | US7528133 Use of thiazolidinediones derivatives for preventing uterine contractions in premature labour or lactation |